About Gamma-sarcoglycan
Gamma-sarcoglycan (SGCG) is a protein
from Homo sapiens identified by UniProt accession
Q13326, 291 residues long.
MolForge cross-references it against 0 known binders and
884 disease associations.
Target properties
| Protein name | Gamma-sarcoglycan |
| UniProt accession | Q13326 |
| Gene | SGCG |
| Organism | Homo sapiens |
| Length | 291 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (884)
Diseases linked to this target (Open Targets).
- autosomal recessive limb-girdle muscular dystrophy type 2C · score 0.80
- autosomal recessive limb-girdle muscular dystrophy · score 0.61
- type 2 diabetes mellitus · score 0.39
- limb-girdle muscular dystrophy · score 0.37
- Abnormality of the musculature · score 0.34
- neurofibrillary tangles measurement · score 0.30
- arterial stiffness measurement · score 0.25
- drug use measurement · score 0.23
- protein measurement · score 0.22
- atrial fibrillation · score 0.21
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13326-F1 | alphafold | PREDICTED | 80.29 | — |
Amino-acid sequence (291 residues)
MVREQYTTAT EGICIERPEN QYVYKIGIYG WRKRCLYLFV LLLLIILVVN LALTIWILKV MWFSPAGMGH LCVTKDGLRL EGESEFLFPL YAKEIHSRVD SSLLLQSTQN VTVNARNSEG EVTGRLKVGP KMVEVQNQQF QINSNDGKPL FTVDEKEVVV GTDKLRVTGP EGALFEHSVE TPLVRADPFQ DLRLESPTRS LSMDAPRGVH IQAHAGKIEA LSQMDILFHS SDGMLVLDAE TVCLPKLVQG TWGPSGSSQS LYEICVCPDG KLYLSVAGVS TTCQEHNHIC L
Explore Gamma-sarcoglycan with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets